行情

CRL

CRL

查尔斯河实验室国际
NYSE

实时行情|Nasdaq Last Sale

140.07
+0.54
+0.39%
盘后: 139.72 -0.35 -0.25% 16:12 11/21 EST
开盘
140.10
昨收
139.53
最高
140.41
最低
138.04
成交量
29.67万
成交额
--
52周最高
149.07
52周最低
103.00
市值
68.41亿
市盈率(TTM)
30.26
分时
5日
1月
3月
1年
5年

分析师评级

15位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CRL 新闻

  • Charles River Laboratories International, Inc. 2019 Q3 - Results - Earnings Call Presentation
  • Seeking Alpha - Article.11/14 17:32
  • Charles River Laboratories: Headwinds Ahead But That's Okay
  • Seeking Alpha - Article.11/13 22:23
  • Charles River Labs Won't See Its Narrow Trading Range Last Forever
  • The Street.11/12 14:36
  • Everything Jim Cramer said about the stock market on 'Mad Money,' including bear woes, Norwegian green initiatives, more market rally, CEO pay
  • CNBC.com.11/12 00:42

更多

所属板块

生物技术和医学研究
-0.38%
制药与医学研究
+0.29%

热门股票

名称
价格
涨跌幅

CRL 简况

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.
展开

Webull提供Charles River Laboratories Intl. Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。